CME & CEU Information

Learning Objectives

The 2008 Annual Meeting will help attendees to:

Incorporate new information about disorders of the cilium and centrosome into their current practice Enhance their understanding of the mechanisms underlying nuclear gene mutations and the clinical features of pediatric mitochondrial disorders
Participate in the dialogue about screening for Duchenne muscular dystrophy and apply current constructs about assessing the best age for screening to their practice
Include rapid new developments in pharmacogenetics in current and future practice
Improve their ability to diagnose and treat patients with inherited cholesterol disorders
Expand their knowledge of balanced chromosome rearrangements and their relevance to clinical practice
Adopt up-to-date practices regarding metabolic approaches to evaluating neurologic problems in childhood
Recognize the clinical phenotypes of deletion 1p36, Coffin-Lowry, Hallerman-Streiff, Ohdo, Schinzel-Giedion and Donnai-Barrow syndromes in practice
Incorporate new knowledge about the role of microRNAs in cancer into patient diagnosis and management
Sharpen their genetic workup of patients with idiopathic and congenital scoliosis by applying new developmental and molecular information
Perform comprehensive genetic assessments of children with autism, incorporating knowledge of new directions in research

Printer Friendly Page



	Continuing Education Self Reporting - click here.
	Welcome Continuing Ed. Self Reporting General Meeting Information Sessions & Events Schedule-at-a-Glance Registration Hotel Information Exhibitor Information Exhibit Hall Abstracts CME & CEU Information Speakers/Presenters Contact Us Future ACMG Meetings ACMG Web Site	CME & CEU Information Learning Objectives The 2008 Annual Meeting will help attendees to: Incorporate new information about disorders of the cilium and centrosome into their current practice Enhance their understanding of the mechanisms underlying nuclear gene mutations and the clinical features of pediatric mitochondrial disorders Participate in the dialogue about screening for Duchenne muscular dystrophy and apply current constructs about assessing the best age for screening to their practice Include rapid new developments in pharmacogenetics in current and future practice Improve their ability to diagnose and treat patients with inherited cholesterol disorders Expand their knowledge of balanced chromosome rearrangements and their relevance to clinical practice Adopt up-to-date practices regarding metabolic approaches to evaluating neurologic problems in childhood Recognize the clinical phenotypes of deletion 1p36, Coffin-Lowry, Hallerman-Streiff, Ohdo, Schinzel-Giedion and Donnai-Barrow syndromes in practice Incorporate new knowledge about the role of microRNAs in cancer into patient diagnosis and management Sharpen their genetic workup of patients with idiopathic and congenital scoliosis by applying new developmental and molecular information Perform comprehensive genetic assessments of children with autism, incorporating knowledge of new directions in research Printer Friendly Page